Latest filing published 27 Feb 2024 for T2 Biosystems, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -13.4%Entry US$48.50 · Close at T+365 US$42.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John M. Sprague: trading record in brief
John M. Sprague (finance chief) discloses dealings in T2 Biosystems, Inc. to SEC (Form 4). Between 28 June 2018 and 24 February 2024, the trades on record add up to 21 filings.
Both buying and selling appear: 1 purchase worth €4,388, against 4 sales worth €14k. On balance, insiders were net sellers of €9,148. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants and 11 option exercises.
The newest entry dates from 27 February 2024: an option exercise, in T2 Biosystems, Inc. The clock since the last published purchase (11 April 2022) now reads 1,672 days. Filings reach the SEC (Form 4) feed a median of 6 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John M. Sprague
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 29 sharesCommon StockSEC:0000950170-24-021243:0
- 40 sharesCommon StockSEC:0000950170-24-017070:0
- 1,545 shares@ US$0.650.0% of flowCommon StockSEC:0000899243-23-007726:1
- 1,148 shares@ US$0.590.0% of flowCommon StockSEC:0000899243-23-007726:3
- 2,914 sharesCommon StockSEC:0000899243-23-007726:2
- 4,000 sharesCommon StockSEC:0000899243-23-007726:0
- 10,000 shares@ US$0.4767100.0% of flowCommon StockSEC:0000899243-22-014414:0Canonical exit: 7 Jul 2022 (T+90)
- 10,000 sharesCommon StockSEC:0000899243-22-012641:0
- 145,719 sharesCommon StockSEC:0000899243-22-012648:0
- 55,008 shares@ US$0.4488Common StockSEC:0000899243-22-008056:1
- 145,719 sharesCommon StockSEC:0000899243-22-008056:0
- 3,775 shares@ US$0.466Common StockSEC:0000899243-22-007492:1
- 10,000 sharesCommon StockSEC:0000899243-22-007492:0
- 5,250 shares@ US$2.040.0% of flowCommon StockSEC:0000899243-21-007774:1
- 10,000 sharesCommon StockSEC:0000899243-21-007774:0
- 10,000 sharesCommon StockSEC:0000899243-20-006668:0
- 4,166 shares@ US$0.820.0% of flowCommon StockSEC:0000899243-20-006668:1
- 5,619 shares@ US$6.720.1% of flowCommon StockSEC:0000899243-18-020506:0
- 17,292 shares0Common StockSEC:0000899243-18-018683:0
19 of 19 declarations